Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

SHSE:605016 Voorraadrapport

Marktkapitalisatie: CN¥5.6b

Shandong Bailong Chuangyuan Bio-Tech Beheer

Beheer criteriumcontroles 4/4

Shandong Bailong Chuangyuan Bio-Tech's CEO is Hongjian Zhuo, appointed in Sep 2019, has a tenure of 5.17 years. directly owns 0.18% of the company’s shares, worth CN¥10.26M. The average tenure of the management team and the board of directors is 2.2 years and 7.7 years respectively.

Belangrijke informatie

Hongjian Zhuo

Algemeen directeur

CN¥1.1m

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO5.2yrs
Eigendom CEO0.2%
Management gemiddelde ambtstermijn2.2yrs
Gemiddelde ambtstermijn bestuur7.7yrs

Recente managementupdates

Recent updates

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.'s (SHSE:605016) Intrinsic Value Is Potentially 78% Above Its Share Price

Oct 14
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.'s (SHSE:605016) Intrinsic Value Is Potentially 78% Above Its Share Price

Many Still Looking Away From Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016)

Sep 29
Many Still Looking Away From Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016)

Here's Why Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Has Caught The Eye Of Investors

Aug 23
Here's Why Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Has Caught The Eye Of Investors

Returns On Capital At Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Have Hit The Brakes

Jun 26
Returns On Capital At Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Have Hit The Brakes

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016) Analysts Are More Bearish Than They Used To Be

May 06
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016) Analysts Are More Bearish Than They Used To Be

Concerns Surrounding Shandong Bailong Chuangyuan Bio-Tech's (SHSE:605016) Performance

May 03
Concerns Surrounding Shandong Bailong Chuangyuan Bio-Tech's (SHSE:605016) Performance

If EPS Growth Is Important To You, Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Presents An Opportunity

Mar 27
If EPS Growth Is Important To You, Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Presents An Opportunity

CEO

Hongjian Zhuo (46 yo)

5.2yrs

Tenure

CN¥1,101,600

Compensatie

Mr. Hongjian Zhuo is MD & Director of Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. He was Director and General Manager of Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Hongjian Zhuo
MD & Director5.2yrsCN¥1.10m0.18%
CN¥ 10.3m
Li Li
Chief Financial Officer2.2yrsCN¥144.80kgeen gegevens
Anguo Zhang
Deputy General Manager2.2yrsCN¥169.30k0.27%
CN¥ 15.0m
Jun Wei
Deputy General Manager8.2yrsCN¥103.30kgeen gegevens
Wenping Yu
Deputy General Manager2.2yrsCN¥250.10k0.0073%
CN¥ 404.9k
Mingjing Shang
Accounting Supervisorno datageen gegevensgeen gegevens
Junchao Gu
Board Secretary2.2yrsCN¥106.80kgeen gegevens

2.2yrs

Gemiddelde duur

46yo

Gemiddelde leeftijd

Ervaren management: 605016's management team is considered experienced (2.2 years average tenure).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Hongjian Zhuo
MD & Directorno dataCN¥1.10m0.18%
CN¥ 10.3m
Deshan Zhang
Employee Supervisorno datageen gegevensgeen gegevens
Jiang Xia
Independent Directorno dataCN¥72.00kgeen gegevens
Wanqing Zheng
Independent Director8.2yrsCN¥72.00kgeen gegevens
Lianlian An
Deputy GM & Vice Chairmanno dataCN¥1.10m0.29%
CN¥ 16.3m
Baode Dou
Chairman of the Board8.2yrsCN¥731.20k47.36%
CN¥ 2.6b
Xinrong Wang
Director8.2yrsCN¥72.00kgeen gegevens
Weitao Qi
Director7.2yrsgeen gegevensgeen gegevens
Zhang Zhao
Director5.9yrsgeen gegevensgeen gegevens
Zhaobo Gan
Chairman of the Supervisory Boardno datageen gegevens0.00053%
CN¥ 29.5k
Xianbao Shao
Supervisorno datageen gegevensgeen gegevens
Zheng Dan
Independent Director2.2yrsCN¥72.00kgeen gegevens

7.7yrs

Gemiddelde duur

47.5yo

Gemiddelde leeftijd

Ervaren bestuur: 605016's board of directors are considered experienced (7.7 years average tenure).